Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention ...

Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ...

December 02, 2025-- ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced ...

From a modest lab in Israel to an idea potentially able to touch lives around the world, Polyrizon's journey embodies the grit of biotech entrepreneurship. As clinical horizons loom, the company ...

A few days of immunity-boosting Ayurvedic tablets and kaada, the constant companionship of the air purifier, some ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The Global Nasal Drug Delivery Market presents opportunities driven by increased patient preference for non-invasive methods, rising chronic respiratory conditions, and innovations in nose-to-brain ...

Abbad Toma explains how to identify complications before going ahead with dental implant surgery, plus how to manage and ...

Polyrizon (PLRZ) announced new preclinical data showing its proprietary naloxone hydrogel adheres to nasal tissue longer than an approved and ...

The human papillomavirus (HPV) vaccine is a triumph of modern medicine—but it cannot eliminate an existing infection. Once HPV takes hold, no approved vaccines can stop its progression to cervical ...

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by the human papillomavirus (HPV), a viral infection that spreads ...

Nosebleeds, or epistaxis, are common but can signal serious issues, especially for those with high blood pressure or on blood thinners. Minor trauma, ...